RS

Razia Sulthan Vempalle

Active Director Director DIN 08860887
DIN 08860887 First appointment Sep 2020 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Razia Sulthan Vempalle

Data last updated:

Razia Sulthan Vempalle is a Director at Clintek Life Sciences Private Limited (since 2020). The company operates in Information Technology.

DIN 08860887
Primary Designation Director
Industry Information Technology
First Appointment 03 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20202020Active

Board colleagues of Razia Sulthan Vempalle

Directorship timeline

Open interactive timeline →
Clintek Life Sciences Private Limited
Premium access

Shareholding and investment profile for Razia Sulthan Vempalle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Razia Sulthan Vempalle

Razia Sulthan Vempalle currently holds 1 directorship: Clintek Life Sciences Private Limited (Director, since 03 Sep 2020).

Razia Sulthan Vempalle was first appointed on 03 Sep 2020 as Director at Clintek Life Sciences Private Limited.

The current boards of Razia Sulthan Vempalle's companies include Monisa Vempalle (Clintek Life Sciences Private Limited), Monisa Vempalle (Clintek Life Sciences Private Limited), Sulaiman Vempalle (Clintek Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available